
Accelerated underwriting trends:
A Canadian market perspective
properties.trackTitle
properties.trackSubtitle
What is accelerated underwriting?
Accelerated underwriting (AUW) is a program where traditional life insurance underwriting requirements are not required for a subset of applicants that meet favourable risk requirements in an otherwise fully underwritten process. However, even within that definition, the implementation of AUW can vary from one insurer to the next. For instance:
- Insurers may use different types of underwriting analytics—ranging from smoker propensity to BMI misrepresentation models—alongside more traditional underwriting rules.
- Typically, if an applicant successfully “passes” the models, a policy can be issued on a fluidless (“No Fluid”) basis without the need for a paramedical. However, some insurers also layer on the use of attending physician statements (APS) to mitigate the impact of the foregone fluids and vitals.
- If the underwriting models flag a concern, then the applicant is targeted for additional underwriting requirements, reverting back to a more traditional full underwriting approach.
- Applicants can also be randomly selected, or “held out”, for additional underwriting requirements. This allows insurers to measure the performance of their AUW programs.
Regardless of the varying nuances of how AUW is implemented, the goal remains consistent across insurers: reduce the level of cumbersome evidence collected to improve the process for the customer, advisor, and insurer.
For consistency, this article will adhere to the Munich Re definition of AUW: face amounts and issue ages that are eligible for No Fluid, that use underwriting analytics, and that employ a holdout program.

History and current state of AUW in Canada
AUW programs are a growing practice in Canada, with the 2020 pandemic propelling their development. In 2017, only one Canadian insurer offered an AUW program. By 2023, this increased to 10 insurers, with additional companies looking to develop their own programs in the future. For customers, the growing availability of AUW programs has resulted in clear improvements by providing a faster, less invasive buying experience for the majority of life insurance applicants.
For insurers, the implementation of AUW programs has enabled companies to extend improved buying experiences to more customers through higher No Fluid limits. As shown in Figure 1, AUW programs have allowed insurers to increase the maximum No Fluid limit at issue age 45 from $1,000,000 in 2017 to $5,000,000 in 2023, with a corresponding increase in the Individual Life No Fluid percentage by face amount from 29% to 54% over the same years.

The increase in No Fluid percentage over these same years is also reflected in a decrease in placement time for Individual Life, Fully Underwritten applications, as shown in Figure 2. This increase is not without risks, however. For example, one ever-present concern when liberalizing underwriting requirements is the risk of anti-selection, i.e., when applicants or advisors apply for insurance with additional knowledge about their own health and lifestyle, knowing that fluids will likely not be collected.
However, Figure 2 also shows that placement breakdowns—including placement rates, applications placed standard, applications declined/postponed, and wastage—have remained steady despite the removal of fluids for the majority of policies. This is one possible indication that the risk mitigants introduced by insurers have been effective at identifying the right risks.

Risk mitigants for insurers can take a variety of forms. For instance, advances in computing technology and artificial intelligence have propelled the development of underwriting analytics for insurance. Insurers are increasingly incorporating predictive models in their underwriting processes, whether for triage or decisioning. In Canada, this mainly consists of misrepresentation models, which identify applicants misrepresenting disclosures that would otherwise result in a material difference in underwriting outcome. Smoker and body mass index (BMI) misrepresentation models are currently the most common form of underwriting analytics across AUW programs in Canada; all insurers with AUW programs either have at least one of these models already, or are looking to add more models to strengthen their AUW capabilities.
The implementation of underwriting analytics has also allowed insurers to introduce holdouts to their AUW programs. Holdouts are cases in the No Fluid underwriting workflow that are selected for additional requirements, which could include some combination of fluids, vitals, and/or non-routine APS:
- Random holdouts (RHOs) are selected randomly or chronologically and can be used by insurers to understand the impact of their AUW program on their underwriting decisions.
- Targeted holdouts (THOs) are selected by underwriting analytics and allow insurers to liberalize underwriting requirements while still enforcing additional scrutiny where warranted.
Insurers use one or both types of holdouts to enhance their risk monitoring and risk selection capabilities. In Canada, holdouts are most commonly implemented for face amounts over $500,000, at levels of approximately 10% of policies submitted for RHOs, and 14% for THOs.
Figure 3 shows that Munich Re’s Individual Insurance Survey participants have significantly increased their usage of underwriting analytics and holdouts over the last five years. Insurers are continually refining and enhancing their AUW program holdout levels to increase confidence in their accelerated decisions, while balancing customer and advisor experiences.

Looking ahead: The future of AUW
Mortality slippage
One important ongoing concern across the industry is mortality slippage, which is the deterioration of mortality introduced by the removal of traditional underwriting requirements in the underwriting process. This risk arises because the removal of fluid requirements from AUW programs introduces the risk of misrating applicants and/or issuing policies to applicants that should have otherwise been declined. With AUW becoming increasingly widespread, understanding mortality slippage and how it can be mitigated and priced accordingly is of utmost importance.
Companies should work to effectively and continuously monitor mortality slippage on AUW business, keeping in mind that the ability to collect and report data on the underwriting path taken by each policy is a crucial component of these monitoring efforts. Today, there is no universal approach used by Canadian insurers to calculate slippage, but Munich Re is actively working with clients to determine the best approach to calculating slippage within the client’s underwriting framework.
Wastage
Wastage is the broad category referring to submitted applications that are not proceeded with, closed out as incomplete, or offered but not taken by the applicant. Understanding wastage can help insurers gain insight into their AUW program effectiveness. In general, wastage levels are lower for applications that were decisioned without additional evidence through the AUW program and higher for holdouts, suggesting that wastage is influenced by the amount of evidence collected.
Above-average wastage on holdouts could indicate that a company’s AUW program is disproportionately attracting adverse risks and that the subsequent wastage is selective. Selective wastage happens when a customer walks away from their insurance application specifically to avoid giving evidence to the insurer that will adversely impact their insurance eligibility and/or premium. It has been observed that wastage levels are higher for THOs than RHOs, which is indicative of the selective nature of wastage and an implication of underlying misrepresentation. This comes with the added implication that RHO results are no longer truly random, as they represent a skewed proportion of applicants who were willing to provide evidence.
Priorities and challenges
Priorities and challenges regarding AUW can vary depending on the insurer's size and the maturity of its AUW program.
For insurers in the early stages of building an AUW program, priorities revolve around the development and implementation of underwriting analytics. To do so, companies need to ensure that they have access to sufficient data (i.e., underwriting, inforce, and experience data), and that this data is available in a digital format that can be integrated into their current systems. However, this is also where the main challenges lie for these companies, as digitalization, data integration, and model building are highly resource-intensive.
Insurers with more mature AUW programs tend to have more data and experience to work with, allowing them to focus instead on enhancing their underwriting analytics capabilities. Part of these enhancements could involve:
- Limiting bias and improving monitoring of their existing models
- Developing the next generation of models
- Decommissioning models that don’t add enough value
- Moving away from RHOs to THOs
Data sources
Across the industry, insurers are looking toward leveraging both new and existing data sources, but the availability and quality of this data pose challenges for the Canadian insurance landscape. One industry development we could hope to see is the incorporation of new data sources in underwriting, similar to the U.S. approach, which increasingly uses digital health data with information on applicant health histories.
Through our firsthand experience in the U.S., as well as preliminary analyses of available Canadian data, we have observed the protective value of certain third-party data sources, such as clinical labs and electronic health records (EHRs). These data sources can potentially provide an alternative to traditional insurance labs, changing the way we approach risk assessment. For example, some of these data sources offer a longitudinal view of the applicant’s health, thus allowing trends to be identified. They could also offer alternative information not readily obtained via insurance labs, such as complete blood counts (CBCs).
These novel data sources could be used in underwriting to improve the client experience via faster decisioning, without eroding mortality experience.
Contact the author
